![Michael Schirner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Dr. Michael Schirner, MD, is a Managing Director at mivenion GmbH.
Dr. Schirner was previously employed as a Principal by Schering AG.
He received his undergraduate degree from the Friedrich Schiller University of Jena and a doctorate degree from Martin-Luther-Universität Halle-Wittenberg.
Antiguos cargos conocidos de Michael Schirner.
Empresas | Cargo | Fin |
---|---|---|
Bayer Schering Pharma AG | Corporate Officer/Principal | 01/01/2007 |
mivenion GmbH
![]() mivenion GmbH Medical SpecialtiesHealth Technology mivenion GmbH offers personalized medical solutions for patients with inflammatory and autoimmune diseases. Its flagship product, Xiralite, enables the Rheumascan procedure that provides integrated solution for patients with inflammatory diseases in the hands. The company was founded by Michael Schirner and Malte Bahner in 2007 and is headquartered in Berlin, Germany. | Director Ejecutivo | - |
Formación de Michael Schirner.
Friedrich Schiller University of Jena | Undergraduate Degree |
Martin-Luther-Universität Halle-Wittenberg | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
mivenion GmbH
![]() mivenion GmbH Medical SpecialtiesHealth Technology mivenion GmbH offers personalized medical solutions for patients with inflammatory and autoimmune diseases. Its flagship product, Xiralite, enables the Rheumascan procedure that provides integrated solution for patients with inflammatory diseases in the hands. The company was founded by Michael Schirner and Malte Bahner in 2007 and is headquartered in Berlin, Germany. | Health Technology |
Bayer Schering Pharma AG | Health Technology |
- Bolsa de valores
- Insiders
- Michael Schirner